Global Preeclampsia Drugs Market
市场规模(十亿美元)
CAGR : %
Forecast Period |
2023 –2030 |
Market Size (Base Year) |
USD 1.00 Billion |
Market Size (Forecast Year) |
USD 2.14 Billion |
CAGR |
|
Major Markets Players |
|
>全球先兆子痫药物市场,按类型(轻度先兆子痫、重度先兆子痫)、治疗(降压药物、皮质类固醇和抗惊厥药物)、给药途径(口服、肠外、其他)、最终用户(医院、专科诊所、诊断中心和其他)、分销渠道(医院药房、零售药房、网上药房和其他)划分 - 行业趋势和预测到 2030 年。
先兆子痫药物市场分析和规模
子痫前期的发生率在世界各地差异很大。世界卫生组织估计,发展中国家的子痫前期发生率(占活产婴儿的 2.8%)是发达国家(占 0.4%)的七倍。市场上的几家市场参与者宣布推出新产品以增加对该产品的需求。根据《瑞士医学周刊》的报道,患子痫前期的风险包括未产、已有高血压、既往子痫前期、肾脏疾病。
Data Bridge Market Research 分析了 2023-2030 年预测期内先兆子痫药物市场的增长率。在上述预测期内,先兆子痫药物市场的预期复合年增长率往往在 10% 左右。2022 年市场价值为 10 亿美元,到 2030 年将增长至 21.4 亿美元。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外,Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、渠道分析、定价分析和监管框架。
先兆子痫药物市场范围和细分
报告指标 |
细节 |
预测期 |
2023 至 2030 年 |
基准年 |
2022 |
历史岁月 |
2021(可定制为 2015 - 2020) |
定量单位 |
收入(单位:十亿美元)、销量(单位:台)、定价(美元) |
涵盖的领域 |
类型(轻度先兆子痫、重度先兆子痫)、治疗(降压药、皮质类固醇和抗惊厥药)、给药途径(口服、肠外、其他)、最终用户(医院、专科诊所、诊断中心等)、分销渠道(医院药房、零售药房、网上药房等) |
覆盖国家 |
北美洲的美国、加拿大和墨西哥、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、巴西、阿根廷和南美洲其他地区 |
涵盖的市场参与者 |
Thermo Fisher Scientific Inc. (U.S.), Baxter (U.S.), Bayer AG (Germany), Merck & Co., Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Siemens Healthcare GmbH (Germany), PerkinElmer Inc (U.S.), Sera Prognostics (U.S.), DRG INSTRUMENTS GMBH (Germany), Metabolomic Diagnostics (Ireland), Diabetomics, Inc. (U.S.) |
Market Opportunities |
|
Market Definition
Preeclampsia is a pregnancy complication that is characterized by high blood pressure and signs of damage to another organ system, specifically the liver and kidneys. Preeclampsia generally begins after 20 weeks of pregnancy in women whose B.P. had been normal. It is typically characterized by a sudden onset of high blood pressure, extreme swelling of the hands and face, and dysfunctionality of a few organs that may not work normally, including protein in the urine.
Global Preeclampsia Drugs Market Dynamics
Drivers
- Increasing Incidence of Preeclampsia
According to the records of American Heart Association, Inc., the greatest morbidity and mortality, preeclampsia affects around 5% to 7% of all pregnant women; though, it is responsible for over 70, 000 maternal deaths and 500,000 fetal deaths worldwide each year. Thus, this increasing prevalence demands high use of drugs which benefits the market growth.
- Growing Prevalence of Lifestyle Diseases
As per the American Diabetes Association, cardiovascular disease, cancer, and diabetes account for around two-thirds of the total deaths in the U.S. and US$ 700 billion in direct and indirect economic costs every year. These diseases undermine health, cause enormous suffering and disability, shorten life expectancy, and cost high economic cost. The doctor may suggest a daily low-dose aspirin beginning after 12 weeks of pregnancy. Patients also might benefit from several calcium supplements to prevent preeclampsia. Thus, this factor enhances the market size.
Opportunities
- Availability of different diagnostic tests
There are several diagnostic tests that are available for diagnosing preeclampsia drugs are creating much opportunities for the market growth. The development of innovative preeclampsia diagnostic procedure is projected to improve the adoption of the diagnostic procedure. The rising incidence of the disorder in pregnant women across the globe is anticipated to enhance the diagnostics’ adoption. For instance, according to the NCBI’s research published in July 2021, preeclampsia incidence in France reached around 8.5% among pregnant women. These factors may drive the preeclampsia diagnostics market growth.
- Increasing Demand for Advanced Treatments
Several women having preeclampsia drugs are treated caesarean C-section to have a lower risk of complications. During labor and following delivery, people with preeclampsia are often given magnesium intravenously to prevent the development of eclampsia. This creates more opportunity for the market growth.
Restraints/Challenges
- Lack of skilled professionals
缺乏无法进行这些治疗的合格医疗专业人员可能会在预测期内降低全球先兆子痫药物市场的增长。
- 成本高
手术和治疗过程所需的巨额开支阻碍了市场的增长。许多市场参与者投入巨额资金安装新的和先进的治疗程序以加快恢复过程,但成本却因此增加。
本先兆子痫药物市场报告详细介绍了最新发展、贸易法规、进出口分析、生产分析、价值链优化、市场份额、国内和本地市场参与者的影响,分析了新兴收入领域的机会、市场法规的变化、战略市场增长分析、市场规模、类别市场增长、应用领域和主导地位、产品批准、产品发布、地域扩展、市场技术创新。如需了解有关先兆子痫药物市场的更多信息,请联系 Data Bridge Market Research 获取分析师简报,我们的团队将帮助您做出明智的市场决策,实现市场增长。
COVID-19对全球先兆子痫药物市场的影响
由于医疗保健行业对先兆子痫诊断程序的需求不断增加,该市场在疫情期间受到了积极影响。先兆子痫病例的增加导致多种治疗程序和诊断程序迅速被采用。此外,在后疫情时代,政府指导方针(例如鼓励采用此类程序的修正案)预计将增加对该产品的需求。此外,由于该程序的广泛采用,市场参与者的收入大幅增加。这些因素影响了疫情期间的行业增长
最新动态:
- 2021 年 7 月,LifeCell Diagnostics 宣布在印度开展全面的先兆子痫筛查。目的是检测生物标志物 sFLT-1(可溶性 FMS 样酪氨酸激酶-1),这将能够预测疾病,并有助于在妊娠晚期进行准确诊断
全球先兆子痫药物市场范围
先兆子痫药物市场根据类型、治疗、给药途径、分销渠道和最终用户进行细分。这些细分市场之间的增长将帮助您分析行业中增长缓慢的细分市场,并为用户提供有价值的市场概览和市场洞察,帮助他们做出战略决策,确定核心市场应用。
类型
- 轻度先兆子痫
- 严重先兆子痫
治疗
- 降血压药物
- 皮质类固醇
- 抗惊厥药物
给药途径
- 口服
- 肠外
- 其他的
最终用户
- 医院
- 专科诊所
- 诊断中心
- 其他的
分销渠道
- 医院药房
- 零售药店
- 网上药店
- 其他的
先兆子痫药物市场区域分析/见解
对先兆子痫药物市场进行了分析,并按类型、治疗、给药途径、分销渠道和最终用户提供了市场规模洞察和趋势。
先兆子痫药物市场报告涉及的主要国家 有:北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。
由于患者和医疗保健提供者对疾病严重性的认识不断提高,美国在预测期内占据市场主导地位
亚太地区被认为是最有利可图的时期,因为医疗保健支出增加和技术先进的药物的采用将增加该地区先兆子痫药物市场的增长
报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和国内市场监管变化。此外,在提供国家数据预测分析时,还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈竞争或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
竞争格局和全球先兆子痫药物市场份额分析
先兆子痫药物市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对先兆子痫药物市场的关注有关。
先兆子痫药物市场的主要参与者包括:
- 赛默飞世尔科技公司(美国)
- 百特(美国)
- 拜耳公司(德国)
- 默克公司(美国)
- F. Hoffmann-La Roche Ltd.(瑞士)
- 西门子医疗有限公司(德国)
- PerkinElmer Inc(美国)
- Sera Prognostics(美国)
- DRG INSTRUMENTS GMBH(德国)
- 代谢组学诊断(爱尔兰)
- Diabetomics, Inc.(美国)
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.